Twin Tree Management’s Takeda Pharmaceutical TAK Stock Holding History

Twin Tree Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-388	Closed	-$5.39K	–	1646
2024 Q1	$5.39K	Buy	388 +159	+69%	+$2.31K	﹤0.01%	1213
2023 Q4	$3.27K	Sell	229 -153,664	-100%	-$2.18M	﹤0.01%	1330
2023 Q3	$2.38M	Buy	153,893 +149,340	+3,280%	+$2.31M	0.01%	841
2023 Q2	$71.5K	Sell	4,553 -46,476	-91%	-$761K	﹤0.01%	1146
2023 Q1	$841K	Sell	51,029 -56,653	-53%	-$902K	﹤0.01%	1028
2022 Q4	$1.68M	Buy	+107,682	New	+$1.5M	﹤0.01%	964
2021 Q2	–	Sell	-167,007	Closed	-$2.84M	–	1600
2021 Q1	$3.05M	Sell	167,007 -202,113	-55%	-$3.64M	0.01%	757
2020 Q4	$6.72M	Buy	369,120 +365,891	+11,331%	+$6.42M	0.03%	540
2020 Q3	$58K	Sell	3,229 -13,187	-80%	-$240K	﹤0.01%	1093
2020 Q2	$294K	Buy	+16,416	New	+$295K	﹤0.01%	1215

Other funds holding TAK

GAM

Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Twin Tree Management's TAK Position: Q2 2024 in Review

Twin Tree Management sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 388 shares — an estimated $5.39K sold.

Twin Tree Management first reported a position in TAK in Q2 2020 and held it in 10 quarters. The position peaked at $6.72M in Q4 2020. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

Twin Tree Management reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Twin Tree Management sold 388 Takeda Pharmaceutical shares in Q2 2024, an estimated $5.39K.
Twin Tree Management first reported a position in Takeda Pharmaceutical in Q2 2020 and held it in 10 quarters.
Twin Tree Management's Takeda Pharmaceutical position peaked at $6.72M in Q4 2020.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Twin Tree Management's 13F filing for Q2 2024, filed 13 Aug 2024.